03.02.2011 • News

Dr. Bernhard Düttmann to Become Chief Financial Officer (CFO) of Lanxess

Dr. Bernhard Duettmann, next Lanxess CFO
Dr. Bernhard Duettmann, next Lanxess CFO

The Supervisory Board of Lanxess agreed today to revoke the contract of Matthias Zachert (43), Member of the Board of Management and Chief Financial Officer, as of March 31, 2011. Zachert had requested the Board to do so accordingly. In his current function, he has been a Member of the Board of Management since 2004.

Dr. Bernhard Düttmann (51), previously Member of the Board of Management and Chief Financial Officer of Beiersdorf, Hamburg, has been appointed Member of the Board of Management and Chief Financial Officer of Lanxess as of April 1, 2011.

"The Supervisory Board is pleased to have gained an experienced Chief Financial Officer of a recognized company for the CFO role at Lanxess and would like to wish him success in his new position."

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.